Ben Albright MD MS

Gynecologic oncologist and health services researcher @UNC_Lineberger @UNCOBGYN @UNCHealthRex @UNCpublichealth Dog lover, trail runner, Kentuckian Tweets my own

[AJOG @AJOG_thegray]

Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer-Maps depicting number of cases of hysterectomy performed for nonmetastatic uterine cancer by state/county relative to gyn oncologist location https://t.co/Ti3gpX47gk

[Charles Ornstein @charlesornstein]

NEW: Texas Banned Abortion. Then Sepsis Rates Soared.

ProPublica’s first-of-its-kind analysis is the most detailed look yet into a rise in life-threatening complications for women experiencing pregnancy loss under Texas’ abortion ban.

https://t.co/0WnTQejtkc

[Shannon Watts @shannonrwatts]

Scotland has detected no cases of cervical cancer in women born between 1988 and 1996 who were fully vaccinated against HPV between the ages of 12 and 13. https://t.co/rsyCur5zbM

[@GynOncJnls @gynoncjnls]

#GCAM 📄 🚨 Adjuvant therapy and recurrence risk in non-myoinvasive high-grade (stage IC) endometrial cancer: A systematic review and meta-analysis
@SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert https://t.co/Ry1HST9Agq

[Anne Knisely, MD @AnneKniselyMD]

Excited to share our QI paper published in AJOG. If you’re not already adding metronidazole to cefazolin for SSI prophylaxis in Gyn surgery, you should start!

Adjusted OR for SSI 0.49 ⬇️ with addition of metronidazole.
@TaylorJolyn @kmschmeler @MDAndersonNews

[Ben Albright MD MS @BenAlbrightMD]

So sad to hear about the passing of @Frumovitz, a legend in our field, an incredibly generous and spirited mentor, and just a wonderful person to his core. He will be missed by so, so many.

[Ovarcome @ovarcome]

"No matter what phase of care someone is in, we should always provide hope" Your words. Our inspiration. We will miss you Dr. @Frumovitz-but your light and your beautiful spirit will shine on. Thank you for all that you have given to us.
In life and beyond, keep Ovarcoming💙

[Ben Albright MD MS @BenAlbrightMD]

@NickBerlin_MD Congratulations!

[Ben Albright MD MS @BenAlbrightMD]

@fumikochino @MDAndersonNews @MSK_RadOnc Congratulations!!!!

[Ben Albright MD MS @BenAlbrightMD]

@KySportsRadio @jkylemann @KyleTucker_ATH

[Ben Albright MD MS @BenAlbrightMD]

"Entitlement leads to sorrow. Gratitude leads to joy."
-Mark Pope 4.14.24 #BBN

[X. Mona Guo, MD @xmGuo]

@BenAlbrightMD at #SGOMtg on the platinum #chemo shortage in #GynecologicCancer: With a 6-month shortage, ~1654 life-years lost and 594 excess deaths could be mitigated with policy changes and #supplychain investment @GYNCancer @SGO_org

[Zack Cooper @zackcooperYale]

This is a terrible decision by @CMSGov that will harm research, harm health policy, and harm health outcomes. It will damage work done by clinical researchers like @hmkyale and health economists like @asacarny. With changes like this, there would be no @DartmouthInst Atlas.

[Ben Albright MD MS @BenAlbrightMD]

Per 2023 endometrial staging, what stage is clear cell carcinoma with no myometrial invasion but with extensive LVSI? Struggling with these new guidelines…

[Ben Albright MD MS @BenAlbrightMD]

Congratulations to UK, this is a great thing for the people of Kentucky #BBN

[University of Kentucky @universityofky]

“Now, no Kentuckian has to leave the state to find outstanding clinical care and access to the latest clinical trials.” -@UKMarkey Director Dr. B. Mark Evers

https://t.co/7n3LxGjuJt

[Matt Jones @KySportsRadio]

Kentucky really needs to #FreeBigZ

[Ben Albright MD MS @BenAlbrightMD]

Thrilled to officially join the @UNC_Lineberger @UNCOBGYN @UNCHealthRex @UNCpublichealth teams as a gynecologic oncologist and health services/policy/outcomes researcher

[Ben Albright MD MS @BenAlbrightMD]

Direct trocar entry with lower incidence of complications compared to open entry and veress needle in meta-analysis of 25 RCTs

[IJGO @IJGOLive]

#OpenAccess clinical article

"Laparoscopic entry techniques: Which should you prefer?" – Raimondo et al.

Read now: https://t.co/tk5BWjzo8R

[Ben Albright MD MS @BenAlbrightMD]

@TeamEndo_MSK 👎

[Ben Albright MD MS @BenAlbrightMD]

👇👇👇

[Andreas Obermair @AndreasObermair]

@DrFMartinelli @ESGO_society @IGCSociety @OncoAlert @gyncsm @pedroramirezMD @leitaomd @RParejaGineOnco @GynMe4 @ENYGO_official @IJGCfellows A staging system will describe the stage (extent) of cancer + is used so that clinicians can compare the stages of their patients. The new proposal is prognostic (not staging) w lots of data that has nothing to do with "extent of disease" (LVSI). @FIGOHQ got it badly mixed up!

[Ben Albright MD MS @BenAlbrightMD]

ok this is going to be interesting…🫠

[IJGO @IJGOLive]

The 2023 FIGO Staging of Endometrial Cancer includes important updates on histological types, tumor patterns, and molecular classification - facilitating evidence-based treatment recommendations and collection of outcomes.

Read open access: https://t.co/R4ulff3cyp